Hu Er Cao

In rats, quercetin co-occurring in the Saxifraga stolonifera extract significantly decreased the glucuronidation of bergenin by inhibiting UGT1A1 and UGT1A3, so that the pharmacokinetics of bergenin from the whole extract differed significantly from those of the pure compound in peak concentration, time to peak, area under the curve, clearance and mean residence time. The demonstration is intra-herbal and in rodents; no human study has tested whether the herb alters the clearance of a conventional UGT1A1 substrate, and quercetin is present in many foods. Patients with Gilbert syndrome or reduced UGT1A1 activity are the group in whom the theoretical margin is narrowest.

The same rat study showed that quercetin in the extract reduced the metabolism of protocatechuic acid by inhibiting catechol-O-methyltransferase. Levodopa is a catechol cleared in part by the same enzyme, and COMT inhibitors are given deliberately to raise its exposure. The extrapolation from a rodent intra-herbal observation to a levodopa interaction has not been tested in any species and should be treated as a flag, not a finding.

In rats with induced hepatic injury the exposure to bergenin after an oral dose rose to 2.11 times normal, peak concentration by 130 percent, and clearance dropped to 55 percent of normal. The herb is prescribed in Chinese practice for heat and toxicity conditions that can accompany liver disease, so the population most likely to receive it is the one in which it accumulates.

Chinese materia medica classifies Hu Er Cao as bitter, pungent, cold and slightly toxic. The Ben Cao Gang Mu states explicitly that used raw it causes vomiting and purging while processing stops that effect, and the classical route for ear disease is the pounded fresh juice dropped into the ear rather than swallowed. The distinction between the external fresh application and internal use of the prepared herb is therefore part of the drug's own tradition, not a modern gloss.